Bronchitis Clinical Trials

4 recruiting

Bronchitis Trials at a Glance

15 actively recruiting trials for bronchitis are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Copenhagen, Bloomsburg, and Caen. Lead sponsors running bronchitis studies include COPD Foundation, ChromX Health, and Asger Sverrild.

Browse bronchitis trials by phase

Treatments under study

About Bronchitis Clinical Trials

Looking for clinical trials for Bronchitis? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting

Lung MRI in Paediatric Lung Disease: MRI in PBB

Protracted Bacterial Bronchitis (PBB)
Sheffield Children's NHS Foundation Trust30 enrolled1 locationNCT07545304
Recruiting

European Registry Study on Lymphatic Interventions

Lymphatic DisordersPlastic BronchitisProtein Losing Enteropathy+2 more
Rigshospitalet, Denmark500 enrolled1 locationNCT07131293
Recruiting
Not Applicable

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

AnginaAcute BronchiolitisAcute Bronchitis+8 more
University Hospital, Caen4,500 enrolled1 locationNCT07359287
Recruiting

Emphysema Research Registry and Biosample Repository

Chronic Obstructive Pulmonary DiseaseEmphysemaChronic Bronchitis
University of Pittsburgh3,000 enrolled1 locationNCT00307281
Recruiting
Phase 4

The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

Acute Bronchitis
SamA Pharmaceutical Co., Ltd296 enrolled1 locationNCT06411925
Recruiting
Not Applicable

Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease

Chronic Bronchitis
Suzhou Hengruihongyuan Medical Technology Co. LTD210 enrolled13 locationsNCT07068438
Recruiting
Not Applicable

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

SinusitisPneumoniaBronchitis+2 more
Geisinger Clinic68 enrolled1 locationNCT06495021
Recruiting
Not Applicable

Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation

Ventilator Associated TracheobronchitisTracheobronchitis
Hospital Sirio-Libanes590 enrolled16 locationsNCT05266066
Recruiting

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Lung CancerLung InfectionCOPD+13 more
ChromX Health10,000 enrolled1 locationNCT06528418
Recruiting
Phase 4

Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

COPD BronchitisPollution Related Respiratory Disorder
National Institute of Respiratory Diseases, Mexico128 enrolled1 locationNCT06571942
Recruiting
Phase 2

Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD

COPDCOPD ExacerbationImmune System Disorder+2 more
Asger Sverrild80 enrolled2 locationsNCT05507242
Recruiting
Phase 2

Biological Effects of Quercetin in COPD Phase II

Chronic Obstructive Pulmonary DiseaseEmphysemaChronic Bronchitis With Airway Obstruction
Temple University30 enrolled1 locationNCT06003270
Recruiting
Not Applicable

Modulation of Gut Microbiota by Probiotic in Children With Respiratory Symptoms

Respiratory Infection (for Example, Pneumonia, Bronchitis)
Min-Tze LIONG120 enrolled1 locationNCT05794815
Recruiting

COPD Patient-Powered Research Network

EmphysemaChronic Obstructive Lung DiseaseChronic Bronchitis+1 more
COPD Foundation75,000 enrolled1 locationNCT02803242
Recruiting

A Feasibility Study: A Safety Evaluation of the Gala Airway Treatment System on Patients with Chronic Bronchitis in Australia

BronchitisEmphysema
Gala Therapeutics Inc.24 enrolled3 locationsACTRN12617000330347